Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply. (10th June 2022) - Pina Vegas, Laura; Claudepierre, Pascal; Sbidian, Emilie